Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Clare Kahn | Director | 2025-03-11 | 1,860 | $5.34 | $9.92kBuy |
Perceptive Advisors LLC | Director | 2025-02-19 | 5,000,000 | $4.03 | $20.15MBuy |
Bain Capital Life Sciences Investors LLC | 10% Owner | 2025-02-19 | 1,000,000 | $4.03 | $4.03MBuy |
Adage Capital Management LP | 10% Owner | 2025-02-18 | 252,545 | $7.56 | $1.91MBuy |
Kevin Tan | CFO Treasurer | 2025-02-14 | 3,164 | $3.96 | $12.53kSell |
Gabriel Brooks | Chief Medical Officer | 2025-02-14 | 3,256 | $3.96 | $12.89kSell |
Alexander Cumbo | President and CEO | 2025-02-14 | 11,365 | $3.96 | $45.01kSell |
Ilan Ganot | Director | 2025-02-14 | 1,711 | $3.96 | $6.78kSell |
Jessie Hanrahan | Chief Regulatory Officer | 2025-02-14 | 3,079 | $3.96 | $12.19kSell |
Paul Herzich | Chief Technology Officer | 2025-02-14 | 2,688 | $3.96 | $10.64kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Rajeev M. Shah | 17.14% | 13,281,046 | $40.51M | Insider |
Ra Capital Management LP | 15.09% | 11,689,948 | $35.65M | Insider |
Ultragenyx Pharmaceutical Inc | 10.10% | 7,825,797 | $23.87M | Insider |
Perceptive Advisors LLC | 8.91% | 6,906,646 | $21.07M | Institution |
Gilad David Hayeem | 6.63% | 5,136,501 | $15.67M | Insider |
Bain Capital Life Sciences Investors LLC | 6.50% | 5,034,582 | $15.36M | Insider |
Ra Capital Management LP | 5.59% | 4,330,446 | $13.21M | Institution |
Bain Capital Life Sciences Investors LLC | 5.21% | 4,034,582 | $12.31M | Institution |
Adam Koppel | 5.21% | 4,034,582 | $12.31M | Insider |
Adage Capital Management LP | 5.16% | 3,995,539 | $12.19M | Insider |